RESULTS OF SYNTAX SCORE 2020 IN NONDIABETIC PATIENTS' PRIOR MYOCARDIAL INFARCTION WITH PRESERVED EJECTION FRACTION
Keywords:
Myocardial infarction, Myocardial revascularization, Percutaneous intervention, SYNTAX score, Mortality, Major adverse cardiovascular events.Abstract
The SYNTAX score is important to choose the optimal revascularization strategy:
coronary artery bypass graft or percutaneous intervention in patients with prior myocardial
infarction. The prognostic value of the score in predicting the rates of major adverse cardiac and
cerebrovascular events (death, stroke, myocardial infarction, or revascularization) in the various
SYNTAX scores substrata (≤22, 23-32, and ≥33) of patients treated by either percutaneous
coronary intervention (PCI) or coronary artery bypass grafting (CABG) became only evident once
the outcome of the SYNTAX trial was unraveled in 2009 (1 year follow up) and 2013 (5 years
follow up). The SYNTAX Score (SS) 2020 and its derived variants intend to provide therapeutic
advice or guidance as to appropriate treatment strategies for individual patients. The new scales
created in recent years serve to improve the prediction of major cardiovascular events and allow
the cardiac team to further optimize the choice of treatment techniques in individual patients.
